PIRET PHARMA
Timeline
9 events since 2022Filings
Financial
Establishments
20222023202420252026
The 2026 accounts are due by 31-07-2027.
2026
Annual accounts 2025 filed NBBabbreviated format · 27 days late
2025
Weakest financial year net €35,490 ▼26.6% The net result drops to €35,490, the lowest from 2023 to 2025.
Equity above €100,000 equity €126,674 ▲38.9% With a profit in every financial year since 2023, equity grows to €126,674.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0783830868
Annual accounts 2024 filed PDFfull format · 61 days late
2024
Highest result from 2023 to 2025 net €48,323 ▲27.6% The operating result of €74,491 and the net result of €48,323 are both a record.
Annual accounts 2023 filed PDFfull format · 28 days late
2022
IncorporationFounding capital of €5,000, 100 shares · Founded by and · (director) and (director) appointed · published on 29-03-20229 points ▸
- Founded by
- Founded by
- The founding capital is €5,000, divided into 100 shares
- The capital is divided into 100 shares
- The registered office is at rue de Beaumont 147, 6030 Charleroi
- The board has 2 directors
- appointed as director
- appointed as director
- acts as permanent representative
- The deed holds 3 more points.
First establishment Place du Perron 20, Charleroi
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank